ICER Report Assumes $2.8m Price For Libmeldy As Orchard Gears Up For US Debut

The drug-pricing watchdog gave the gene therapy for metachromatic leukodystrophy an “A” grade for use in presymptomatic patients receiving the therapy, which already is approved in Europe.